Literature DB >> 8809065

Release of secretory phospholipase A2 from rat neuronal cells and its possible function in the regulation of catecholamine secretion.

A Matsuzawa1, M Murakami, G Atsumi, K Imai, P Prados, K Inoue, I Kudo.   

Abstract

Here we show that secretory phospholipase A2 (sPLA2) that is immunochemically indistinguishable from type II sPLA2 is (i) stored in neuroendocrine cells, (ii) released in response to neurotransmitters or depolarization, and (iii) involved in the regulation of catecholamine secretion by these cells. Rat brain synaptic vesicle fractions contained PLA2 activity, which was neutralized completely by an antibody raised against rat type II sPLA2. sPLA2 immunoreactive with anti-(type II sPLA2) antibody was released from synaptosomes in response to depolarization evoked by a high concentration of potassium in the presence of Ca2+. Rat pheochromocytoma PC12 cells, which differentiated into adherent cells similar to sympathetic neurons in response to nerve growth factor, were used for the detailed analysis of the dynamics and function of sPLA2 in neuronal cells. Antibody against rat type II sPLA2 precipitated approximately 80% of the PLA2 activity in PC12 cell lysates. Transcript for type II sPLA2 was detected in PC12 cells by reverse transcriptase-PCR. When neuronally differentiated PC12 cells were stimulated with carbamylcholine or potassium, sPLA2 was released into the medium and reached a maximal approximately 40% release by 15 min. Inhibitors specific to type II sPLA2 suppressed catecholamine secretion by PC12 cells which had been activated by carbamylcholine. Furthermore, treatment of PC12 cells with exogenous type II sPLA2 alone elicited catecholamine secretion. These observations indicate that sPLA2 released from neuronal cells may regulate the degranulation process leading to release of neurotransmitters and are compatible with our earlier finding that this enzyme is involved in the degranulation of rat mast cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8809065      PMCID: PMC1217675          DOI: 10.1042/bj3180701

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  51 in total

1.  Microdetermination of long-chain fatty acids in plasma and tissues.

Authors:  V P DOLE; H MEINERTZ
Journal:  J Biol Chem       Date:  1960-09       Impact factor: 5.157

2.  A novel type of phospholipase A2 inhibitor, thielocin A1 beta, and mechanism of action.

Authors:  K Tanaka; S Matsutani; K Matsumoto; T Yoshida
Journal:  J Antibiot (Tokyo)       Date:  1992-07       Impact factor: 2.649

3.  Immunochemical detection of arachidonoyl-preferential phospholipase A2.

Authors:  Y Fujimori; M Murakami; D K Kim; S Hara; K Takayama; I Kudo; K Inoue
Journal:  J Biochem       Date:  1992-01       Impact factor: 3.387

Review 4.  Mammalian non-pancreatic phospholipases A2.

Authors:  I Kudo; M Murakami; S Hara; K Inoue
Journal:  Biochim Biophys Acta       Date:  1993-11-03

5.  Antiinflammatory action of thielocin A1 beta, a group II phospholipase A2 specific inhibitor, in rat carrageenan-induced pleurisy.

Authors:  K Tanaka; T Kato; K Matsumoto; T Yoshida
Journal:  Inflammation       Date:  1993-04       Impact factor: 4.092

6.  Antisense inhibition of group II phospholipase A2 expression blocks the production of prostaglandin E2 by P388D1 cells.

Authors:  S E Barbour; E A Dennis
Journal:  J Biol Chem       Date:  1993-10-15       Impact factor: 5.157

7.  Release of 14-kDa group-II phospholipase A2 from activated mast cells and its possible involvement in the regulation of the degranulation process.

Authors:  M Murakami; I Kudo; Y Suwa; K Inoue
Journal:  Eur J Biochem       Date:  1992-10-01

8.  Eicosanoid generation from antigen-primed mast cells by extracellular mammalian 14-kDa group II phospholipase A2.

Authors:  M Murakami; I Kudo; K Inoue
Journal:  FEBS Lett       Date:  1991-12-09       Impact factor: 4.124

9.  cPLA2 is phosphorylated and activated by MAP kinase.

Authors:  L L Lin; M Wartmann; A Y Lin; J L Knopf; A Seth; R J Davis
Journal:  Cell       Date:  1993-01-29       Impact factor: 41.582

10.  Molecular nature of phospholipases A2 involved in prostaglandin I2 synthesis in human umbilical vein endothelial cells. Possible participation of cytosolic and extracellular type II phospholipases A2.

Authors:  M Murakami; I Kudo; K Inoue
Journal:  J Biol Chem       Date:  1993-01-15       Impact factor: 5.157

View more
  20 in total

Review 1.  Role of cytosolic calcium-dependent phospholipase A2 in Alzheimer's disease pathogenesis.

Authors:  M T Gentile; M G Reccia; P P Sorrentino; E Vitale; G Sorrentino; A A Puca; L Colucci-D'Amato
Journal:  Mol Neurobiol       Date:  2012-05-31       Impact factor: 5.590

2.  Differential effects of polyunsaturated fatty acids on membrane capacitance and exocytosis in rat pheochromocytoma-12 cells.

Authors:  Wee-Liat Ong; Bin Jiang; Ning Tang; Su-Fung Ling; Jin-Fei Yeo; Shunhui Wei; Akhlaq A Farooqui; Wei-Yi Ong
Journal:  Neurochem Res       Date:  2006-01       Impact factor: 3.996

Review 3.  The role of secretory phospholipase A₂ in the central nervous system and neurological diseases.

Authors:  Tatsurou Yagami; Yasuhiro Yamamoto; Hiromi Koma
Journal:  Mol Neurobiol       Date:  2013-10-10       Impact factor: 5.590

4.  Effect of n-3 fatty acid deficiency on fatty acid composition and metabolism of aminophospholipids in rat brain synaptosomes.

Authors:  A Ikemoto; M Ohishi; N Hata; Y Misawa; Y Fujii; H Okuyama
Journal:  Lipids       Date:  2000-10       Impact factor: 1.880

5.  Extracellular-derived calcium does not initiate in vivo neurotransmission involving docosahexaenoic acid.

Authors:  Epolia Ramadan; Angelo O Rosa; Lisa Chang; Mei Chen; Stanley I Rapoport; Mireille Basselin
Journal:  J Lipid Res       Date:  2010-04-13       Impact factor: 5.922

6.  Chronic lithium treatment decreases brain phospholipase A2 activity.

Authors:  M C Chang; C R Jones
Journal:  Neurochem Res       Date:  1998-06       Impact factor: 3.996

Review 7.  Lipid signaling in neural plasticity, brain repair, and neuroprotection.

Authors:  Nicolas G Bazan
Journal:  Mol Neurobiol       Date:  2005-08       Impact factor: 5.590

8.  Differential effects of lysophospholipids on exocytosis in rat PC12 cells.

Authors:  May-Thu Ma; Jin-Fei Yeo; Akhlaq A Farooqui; Jing Zhang; Peng Chen; Wei-Yi Ong
Journal:  J Neural Transm (Vienna)       Date:  2010-03       Impact factor: 3.575

Review 9.  Role of secretory phospholipase a(2) in CNS inflammation: implications in traumatic spinal cord injury.

Authors:  W Lee Titsworth; Nai-Kui Liu; Xiao-Ming Xu
Journal:  CNS Neurol Disord Drug Targets       Date:  2008-06       Impact factor: 4.388

10.  Secretory phospholipases A2 induce neurite outgrowth in PC12 cells.

Authors:  Satoru Nakashima; Yutaka Ikeno; Tatsuya Yokoyama; Masakazu Kuwana; Angelo Bolchi; Simone Ottonello; Katsuhiko Kitamoto; Manabu Arioka
Journal:  Biochem J       Date:  2003-12-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.